DiscoverProgress, Potential, and Possibilities Podcast / Show
Progress, Potential, and Possibilities Podcast / Show
Claim Ownership

Progress, Potential, and Possibilities Podcast / Show

Author: Ira Pastor

Subscribed: 5Played: 626
Share

Description

Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor

726 Episodes
Reverse
Send us a text Dr. Jamuna Ravi is the Chief Executive Officer of Vayah Vikas ( https://vayah-vikas.org/ ), an organization dedicated to transforming well-being and quality of life for older adults across India. Under her leadership, Vayah Vikas has emerged as one of the most forward-thinking initiatives in the aging sector—integrating digital health, preventive care, social engagement, and evidence-based longevity practices to support India’s rapidly growing elder population. Dr. Ravi is a s...
Send us a text Dr. Ritu Saluja-Sharma, MD is a double-board–certified physician in Emergency Medicine and Lifestyle Medicine, and the visionary founder of Head Heart Hands ( https://www.headhearthandsmd.com/ ), a comprehensive, holistic wellness program for individuals and organizations. Dr. Saluja-Sharma earned her M.D. from Wake Forest University School of Medicine and completed her undergraduate studies at the University of North Carolina at Chapel Hill. For over 15 years, Dr...
Send us a text Richard Daly is President and Chief Executive Officer of Catalyst Pharmaceuticals ( https://catalystpharma.com/ ), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. Catalyst has successfully brought three therapies to market: FIRDAPSE ( https://firdapse.com/ ) for Lambert Eaton Myasthenic Syndrome (LEMS), AGAMREE ( https://agamree.com/ ) for Duchenne Muscular Dystrophy (...
Send us a text Dr. Carina Kern, Ph.D. is the CEO of LinkGevity ( https://www.linkgevity.com/ ), an AI-powered biotech company driving innovation in drug discovery for aging and resilience loss. Dr. Kern has developed a new Blueprint Theory of Aging, which takes an integrative approach to understanding aging, combining evolutionary theory, genetics, molecular mechanisms and medicine, and is used to structure LinkGevity’s AI. Dr. Kern’s labs are based at the Babraham Researc...
Send us a text Thijs Spoor is Chief Executive Officer at Perspective Therapeutics ( https://perspectivetherapeutics.com/ ), a clinical-stage, radiopharmaceutical company that is pioneering innovative treatments for cancers. The Company’s proprietary technology utilizes the alpha emitting isotope Pb-212 to deliver powerful radiation directly to cancer cells via high-affinity targeting peptides. Prior to this, Thijs was the Chairman at Verifi H2O. Thijs also held the position of Chief Executiv...
Send us a text Neil Klompas, CPA, CA is President, Chief Executive Officer, and Director of Augurex ( https://augurex.com/ ), a leading edge diagnostic company focused on developing and commercializing advanced diagnostics with the aim of improving patient outcomes and ending diagnostic delays in autoimmune conditions. Mr. Klompas has been involved in healthcare and biotechnology for over 30 years in various senior leadership roles spanning operational, financial and research and development...
Send us a text Ben Zimmer is CEO of Priovant Therapeutics ( https://www.priovanttx.com/ ), a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases associated with the greatest morbidity and mortality. Priovant is developing oral brepocitinib, a potential first-in-class dual inhibitor of TYK2 and JAK1, across multiple severe autoimmune indications, unlocking new treatment options for patients who are underserved by existing therapies. Ben joined Pr...
Send us a text Evan Mathis ( https://evanmathis.co/ ) is a three-time Emmy Award–winning, multi-disciplinary creative director and filmmaker whose work spans sports, entertainment, brand storytelling, and cinematic short-form content. Evan recently expanded his creative scope into deeply human, health-centered storytelling with the short film The Hemingway ( https://www.thehemingway.film/ ) which he co-directed with ALS patient Patrick Sean O’Brien. The film offers an intimate, unfiltered, a...
Send us a text Edmund Benami is Co-Founder and CEO of NeuraLight ( https://neuralight.ai/ ), a pioneering health-tech company focused on applying advanced computer vision and deep-learning techniques to accelerate and improve drug development and patient monitoring in neurological diseases. NeuraLight’s mission is to develop objective and sensitive biomarkers in neurology by extracting oculometric markers (measures of eye movement) from standard webcams or smartphones, thereby providin...
Send us a text Les Johnson is a physicist, author, and space technologist ( https://www.lesjohnsonauthor.com/ ) who most recently served as the Chief Technologist at NASA’s George C. Marshall Space Flight Center. Les is also the Founder of Infinite Frontiers Consulting ( https://www.lesjohnsonauthor.com/infinite-frontiers-consulting-llc.html ), an aerospace consulting firm dedicated to helping turn innovative space ventures into reality. After decades leading of missions at NASA and co...
Send us a text Dave Rosa is President & Chief Executive Officer of NeuroOne ( https://nmtc1.com/ ), a developmental-stage medical technology company developing high-definition, minimally invasive thin film electrodes for the diagnosis and treatment of various neurological conditions ( https://nmtc1.com/technology ). The company’s initial focus is on epilepsy and the fast‑growing neurostimulation device market. Mr. Rosa is an entrepreneur with three decades of experience in the medical de...
Send us a text Dr. Julia Moore Vogel, PhD, MBA is Assistant Professor and Senior Program Director at The Scripps Research Institute ( https://www.scripps.edu/science-and-medicine/translational-institute/about/people/julia-moore-vogel/ ) where she is responsible for managing a broad portfolio of patient-centric health research studies, including The Long COVID Treatment Trial ( https://longcovid.scripps.edu/locitt-t/ ), a fully remote, randomized, placebo-controlled clinical trial targeting in...
Send us a text Komeil Nasrollahi is a seasoned innovation and business‐development leader currently serving as Senior Director of Innovation & Venture Partnerships at Siemens Healthineers ( https://www.siemens-healthineers.com/ ), where he is charged with forging strategic collaborations, identifying new venture opportunities and accelerating transformative healthcare technologies. With an academic foundation in industrial engineering from Tsinghua University (and additional studie...
Send us a text Shari and Bill Hall ( https://familiesfightingflu.org/family-story/the-hall-family/ ) are a really remarkable couple whose story shines a light on just how far-reaching the effects of influenza can be — not only for the person who gets sick, but for the loved ones who care for them. What began as an ordinary illness became a life-changing experience for the Hall family, one that tested their strength, deepened their compassion, and opened their eyes to the true impact of flu. ...
Send us a text Dr. Adnan Masood, Ph.D. ( https://medium.com/@adnanmasood ) is Chief AI Architect at UST ( https://www.ust.com/ ), the giant global digital transformation solutions company. Dr. Masood brings over two decades of leadership in artificial intelligence, machine learning, and large-scale system architecture, bridging cutting-edge academic research with real-world business outcomes. At UST, Dr. Masood leads the firm’s global strategy for cognitive computing, AI, ML, an...
Send us a text Ariel Garten is a neuroscientist, innovator, and entrepreneur whose driving purpose is to empower and help others overcome mental obstacles in order to live healthy, happy lives and reach their maximum potential, by harnessing real-time brain data to improve focus, relaxation, and meditation. Ariel is Co-Founder of InteraXon, the makers of Muse: the brain sensing headband ( https://choosemuse.com/ ). Muse is the award-winning wearable, clinical-grade Electroencephalogra...
Send us a text Dr. Fred Grossman, D.O., FAPA is President and Chief Medical Officer of Coya Therapeutics ( https://coyatherapeutics.com/ ), a clinical-stage company focused on developing multi-modality, Regulatory T Cell (Treg) therapies for neurodegenerative diseases. Coya has already developed strong proof of concept data in Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s, and is also active in the autoimmune and metabolic disease domains. Dr. Grossman brings over 20 years of drug deve...
Send us a text Douglas Leech is Founder and CEO of Ascension Recovery Services ( https://www.ascensionrs.com/ ), an organization focused on developing and managing comprehensive, fully integrated behavioral health systems, treating Substance Use Disorders and co-occurring mental illness across the full continuum of care. Mr. Leech has a B.S. degree in Accounting from Pennsylvania State University and worked at Ernst & Young in Pittsburgh before returning to Morgantown, West Virginia and ...
Send us a text Yael Elish is CEO and Founder of StuffThatWorks (https://www.stuffthatworks.health/open-stuff), a company that offers an online platform where people suffering from chronic diseases can share information to learn which treatments work best for their specific condition, based on the experience of their peers combined with a smart, AI-based crowdsourcing system. Last week, StuffThatWorks announced the alpha launch of OpenStuff ( https://www.openstuff.com/open-stuff ), the world’...
Send us a text Joel Krikston is a seasoned executive with extensive experience in venture investments and strategic innovation within the healthcare sector. Joel currently serves as Managing Director Venture Investments Merck Global Health Innovation Fund ( https://www.merckghifund.com/?profile=joel-krikston ) and Co-Founder of MSD Idea Studios ( https://www.msd.de/ideastudio/ ), a global innovation hub organization that is committing $38 million to scale high-impact health technologies that...
loading
Comments 
loading